Highly qualified employment in companies – Highly Qualified Human Resources Contract (SME or CoLAB) (Q2896292)

From EU Knowledge Graph
Revision as of 17:34, 5 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in fr, and other parts: Adding French translations)
Jump to navigation Jump to search
Project Q2896292 in Portugal
Language Label Description Also known as
English
Highly qualified employment in companies – Highly Qualified Human Resources Contract (SME or CoLAB)
Project Q2896292 in Portugal

    Statements

    0 references
    235,778.0 Euro
    0 references
    471,555.0 Euro
    0 references
    50.0 percent
    0 references
    20 November 2019
    0 references
    31 August 2022
    0 references
    LIFEWELL - PHARMACEUTICAL & HEALTHCARE, LDA
    0 references
    0 references
    0 references

    40°50'20.44"N, 8°28'40.01"W
    0 references
    O presente projeto tem como objetivo o reforço das competências da LifeWell nos domínios da qualificação, da investigação e desenvolvimento e inovação (I&D&I) através da contratação de recursos altamente qualificados que contribuem para a consecução da estratégia de inovação, diversificação e crescimento sustentável da empresa, nos segmentos dos suplementos alimentares e medicamentos sujeitos a receita médica (MSRM). (Portuguese)
    0 references
    The present project aims to strengthen Lifewell’s skills in the areas of qualification, research and development and innovation (I &D&I) by hiring highly qualified resources that contribute to achieving the company’s innovation, diversification and sustainable growth strategy in the food supplements and prescription drugs (MSRM) segments. (English)
    8 July 2021
    0 references
    Ce projet vise à renforcer les compétences de Lifewell dans les domaines de la qualification, de la recherche et du développement et de l’innovation (I&D&I) en soustrayant des ressources hautement qualifiées qui contribuent à la réalisation de la stratégie d’innovation, de diversification et de croissance durable de l’entreprise, dans les segments des compléments alimentaires et des médicaments sur ordonnance (MSRM). (French)
    5 December 2021
    0 references
    Oliveira de Azeméis
    0 references

    Identifiers

    NORTE-06-3559-FSE-000059
    0 references